Non-Vascular Central Nervous System Effects of Calcium Entry Blockers
- 1 May 1985
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 5 (2_suppl) , 115-118
- https://doi.org/10.1177/03331024850050s221
Abstract
Calcium entry blocker (CEB) use has been proposed in a variety of neurological dysfunctions. Some of the new clinical applications suggest a direct non-vascular action on neuronal activity. This view is supported by the observation that in brain CEBs bind preferentially to neuronal terminals and not to vascular elements. The data reported indicate that CEBs modify both in vitro and in vivo neurotransmitter release using brain slices and that their binding sites display some degree of plasticity in various experimental conditions altering neuronal transmission.Keywords
This publication has 30 references indexed in Scilit:
- In vivo chronic lead exposure alters [3H]nitrendipine binding in rat striatumBrain Research, 1984
- Calcium entry and calcium entry blockadeCell Calcium, 1984
- [3H] verapamil binding sites in skeletal muscle tranverse tubule membranesBiochemical and Biophysical Research Communications, 1984
- Dihydropyridines as potent calcium channel blockers in neuronal cellsFEBS Letters, 1983
- Calcium antagonists: A new class of drugsPharmacology & Therapeutics, 1983
- Intracelular sites of early calcium accumulation in the rat hippocampus during status epilepticusNeuroscience Letters, 1982
- A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in MigraineHeadache: The Journal of Head and Face Pain, 1981
- Pharmacology of MigraineAnnual Review of Pharmacology and Toxicology, 1981
- A fluorescent histochemical study of changes in noradrenergic neurons following experimental cerebral infarction in the ratBrain Research, 1977
- Interactions of lead and calcium on the synaptosomal uptake of dopamine and cholineLife Sciences, 1977